Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-24-113991
Filing Date
2024-12-31
Accepted
2024-12-31 16:15:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4743
  Complete submission text file 0001213900-24-113991.txt   6570
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Subject) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91969 | Film No.: 241593186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1680 MICHIGAN AVENUE, STE 700 MIAMI FL 33139
Business Address 1680 MICHIGAN AVENUE, STE 700 MIAMI FL 33139 (312) 809-7002
CA PIPE SPV, LLC (Filed by) CIK: 0002048263 (see all company filings)

EIN.: 331955673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G